United States · FDA National Drug Code directory

Topiramate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69097-819_1b47473e-6644-4026-90e5-b169fce62b60
Product NDC: 69097-819
Form: TABLET
Composition / generic term: Topiramate
Labeler: Cipla USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20160722
Source listing expiry: 20261231

Source-listed ingredients

TOPIRAMATE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

60 TABLET in 1 BOTTLE (69097-819-03) · 69097-819-03
500 TABLET in 1 BOTTLE (69097-819-12) · 69097-819-12
1000 TABLET in 1 BOTTLE (69097-819-15) · 69097-819-15

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →